• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过 MMGBSA 方法研究新型表儿茶素衍生物作为 GPER 激动剂的结构和能量基础。

Structural and energetic basis for novel epicatechin derivatives acting as GPER agonists through the MMGBSA method.

机构信息

Laboratorio de Modelado Molecular, Bioinformática y Diseño de Fármacos de la Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico.

Laboratorio de Modelado Molecular, Bioinformática y Diseño de Fármacos de la Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico.

出版信息

J Steroid Biochem Mol Biol. 2019 May;189:176-186. doi: 10.1016/j.jsbmb.2019.03.006. Epub 2019 Mar 6.

DOI:10.1016/j.jsbmb.2019.03.006
PMID:30851383
Abstract

(-)-Epicatechin (Epi) has been demonstrated to activate pathways involved in GPER-stimulated nitric oxide (NO) production via endothelial NO synthase, known as the eNOS/NO pathway. Previous studies combining synthesis of four Epi derivatives demonstrated that Epi and Epi-prop, Epi-4-prop and Epi-5-prop were able to bind GPER by acting as GPER agonists, whereas docking studies allowed observation of structural details of the binding of these derivatives at the GPER binding site. However, due to the nature of past studies, the theoretical methods employed did not allow observation of structural and energetic details linked to ligand binding at the GPER binding site. In this contribution, we explore the structural and energetic changes coupling the binding of Epi and its four derivatives to GPER. To this end, MD simulations on the microsecond scale (1 μs) with an MMGBSA approach were used for each GPER-ligand complex. Energetic analysis demonstrated that incorporation of several aliphatic chains to Epi contributed to increasing the affinity towards the GPER binding site, thus helping to explain the experimental evidence. Structural analysis demonstrated that Epi, Epi-4-prop and Epi-5-prop share more similar interactions at GPER binding sites with similar conformational behavior than with Epi-prop and Epi-Ms. However, Epi-prop had additional residues that could explain its different but related biological effects.

摘要

(-)-表儿茶素(Epi)已被证明通过内皮型一氧化氮合酶(eNOS/NO 途径)激活与 GPER 刺激的一氧化氮(NO)产生有关的途径。先前结合合成四种 Epi 衍生物的研究表明,Epi 和 Epi-prop、Epi-4-prop 和 Epi-5-prop 能够通过充当 GPER 激动剂与 GPER 结合,而对接研究则允许观察这些衍生物在 GPER 结合位点的结合的结构细节。然而,由于过去研究的性质,所采用的理论方法无法观察到与配体在 GPER 结合位点结合相关的结构和能量细节。在这项研究中,我们探讨了将 Epi 及其四种衍生物与 GPER 结合相关的结构和能量变化。为此,使用 MMGBSA 方法对每个 GPER-配体复合物进行了微秒尺度(1 μs)的 MD 模拟。能量分析表明,将几个脂肪链掺入 Epi 有助于增加对 GPER 结合位点的亲和力,从而有助于解释实验证据。结构分析表明,Epi、Epi-4-prop 和 Epi-5-prop 在 GPER 结合位点上具有更多相似的相互作用,具有相似的构象行为,而与 Epi-prop 和 Epi-Ms 相比。然而,Epi-prop 有额外的残基可以解释其不同但相关的生物学效应。

相似文献

1
Structural and energetic basis for novel epicatechin derivatives acting as GPER agonists through the MMGBSA method.通过 MMGBSA 方法研究新型表儿茶素衍生物作为 GPER 激动剂的结构和能量基础。
J Steroid Biochem Mol Biol. 2019 May;189:176-186. doi: 10.1016/j.jsbmb.2019.03.006. Epub 2019 Mar 6.
2
Synthesis of novel (-)-epicatechin derivatives as potential endothelial GPER agonists: Evaluation of biological effects.新型(-)-表儿茶素衍生物作为潜在内皮细胞G蛋白偶联雌激素受体激动剂的合成:生物学效应评估
Bioorg Med Chem Lett. 2018 Feb 15;28(4):658-663. doi: 10.1016/j.bmcl.2018.01.025. Epub 2018 Jan 24.
3
The effects of (-)-epicatechin on endothelial cells involve the G protein-coupled estrogen receptor (GPER).(-)-表儿茶素对内皮细胞的作用涉及G蛋白偶联雌激素受体(GPER)。
Pharmacol Res. 2015 Oct;100:309-20. doi: 10.1016/j.phrs.2015.08.014. Epub 2015 Aug 21.
4
Deciphering the GPER/GPR30-agonist and antagonists interactions using molecular modeling studies, molecular dynamics, and docking simulations.利用分子建模研究、分子动力学和对接模拟来破译 GPER/GPR30 激动剂和拮抗剂的相互作用。
J Biomol Struct Dyn. 2015;33(10):2161-72. doi: 10.1080/07391102.2014.994102. Epub 2015 Jan 14.
5
Understanding the molecular basis of agonist/antagonist mechanism of GPER1/GPR30 through structural and energetic analyses.通过结构和能量分析理解GPER1/GPR30激动剂/拮抗剂机制的分子基础。
J Steroid Biochem Mol Biol. 2016 Apr;158:104-116. doi: 10.1016/j.jsbmb.2016.01.001. Epub 2016 Jan 6.
6
(6-bromo-1,4-dimethyl-9H-carbazol-3-yl-methylene)-hydrazine (carbhydraz) acts as a GPER agonist in breast cancer cells.(6-溴-1,4-二甲基-9H-咔唑-3-基亚甲基)肼(卡巴肼)在乳腺癌细胞中作为G蛋白偶联雌激素受体(GPER)激动剂发挥作用。
Curr Top Med Chem. 2015;15(11):1035-42. doi: 10.2174/1568026615666150317221549.
7
(-)-Epicatechin stimulates mitochondrial biogenesis and cell growth in C2C12 myotubes via the G-protein coupled estrogen receptor.(-)-表儿茶素通过 G 蛋白偶联雌激素受体刺激 C2C12 肌管中的线粒体生物发生和细胞生长。
Eur J Pharmacol. 2018 Mar 5;822:95-107. doi: 10.1016/j.ejphar.2018.01.014. Epub 2018 Jan 20.
8
(-)-Epicatechin metabolites as a GPER ligands: a theoretical perspective.(-)-表儿茶素代谢产物作为G蛋白偶联雌激素受体(GPER)配体:理论视角
Mol Divers. 2025 Jun;29(3):2099-2115. doi: 10.1007/s11030-024-10968-9. Epub 2024 Aug 17.
9
Homology Modeling, Validation and Dynamics of the G Protein-coupled Estrogen Receptor 1 (GPER-1).G蛋白偶联雌激素受体1(GPER-1)的同源建模、验证及动力学
Mol Inform. 2016 Sep;35(8-9):333-9. doi: 10.1002/minf.201501024. Epub 2016 Apr 4.
10
The G-protein coupled estrogen receptor, GPER: The inside and inside-out story.G蛋白偶联雌激素受体GPER:内外兼修的故事
Mol Cell Endocrinol. 2015 Dec 15;418 Pt 3:207-19. doi: 10.1016/j.mce.2015.07.016. Epub 2015 Jul 17.

引用本文的文献

1
GPER in metabolic homeostasis and disease: molecular mechanisms, nutritional regulation, and therapeutic potential.G蛋白偶联雌激素受体在代谢稳态与疾病中的作用:分子机制、营养调控及治疗潜力
J Transl Med. 2025 Aug 26;23(1):960. doi: 10.1186/s12967-025-07005-0.
2
(-)-Epicatechin metabolites as a GPER ligands: a theoretical perspective.(-)-表儿茶素代谢产物作为G蛋白偶联雌激素受体(GPER)配体:理论视角
Mol Divers. 2025 Jun;29(3):2099-2115. doi: 10.1007/s11030-024-10968-9. Epub 2024 Aug 17.
3
Promising Perspectives of the Antiproliferative GPER Inverse Agonist ERα17p in Breast Cancer.
抗增殖 GPER 反向激动剂 ERα17p 在乳腺癌中的前景可期。
Cells. 2023 Feb 18;12(4):653. doi: 10.3390/cells12040653.
4
Computational Approaches for the Discovery of GPER Targeting Compounds.用于发现 GPER 靶向化合物的计算方法。
Front Endocrinol (Lausanne). 2020 Aug 4;11:517. doi: 10.3389/fendo.2020.00517. eCollection 2020.
5
Based on the Virtual Screening of Multiple Pharmacophores, Docking and Molecular Dynamics Simulation Approaches toward the Discovery of Novel HPPD Inhibitors.基于多重药效团的虚拟筛选、对接和分子动力学模拟方法,发现新型 HPPD 抑制剂。
Int J Mol Sci. 2020 Aug 3;21(15):5546. doi: 10.3390/ijms21155546.